Great-West Lifeco Inc. (LON:0AH3)
London · Delayed Price · Currency is GBP · Price in CAD 52.33
0.00 (0.00%)
At close: Jul 28, 2025
Verve Therapeutics Cash Flow Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Net Income | 3,970 | 4,070 | 2,868 | 3,726 | 3,262 | 3,076 | Upgrade |
Depreciation & Amortization | 567 | 556 | 505 | 528 | 523 | 438 | Upgrade |
Gain (Loss) on Sale of Investments | -3,495 | -1,227 | -6,246 | 27,609 | 2,577 | -5,616 | Upgrade |
Change in Accounts Receivable | 60 | 38 | -480 | 1,168 | - | - | Upgrade |
Reinsurance Recoverable | 940 | 586 | 5 | 5,614 | 1,915 | -1,629 | Upgrade |
Change in Insurance Reserves / Liabilities | 6,307 | 5,636 | 9,316 | -25,355 | 1,819 | 14,476 | Upgrade |
Change in Other Net Operating Assets | -1,098 | -5,538 | -4,561 | -8,124 | 845 | 467 | Upgrade |
Other Operating Activities | -2,158 | 964 | 3,869 | -3,553 | 10 | -1,720 | Upgrade |
Operating Cash Flow | 4,331 | 4,751 | 4,828 | 3,772 | 10,373 | 9,610 | Upgrade |
Operating Cash Flow Growth | -15.18% | -1.59% | 28.00% | -63.64% | 7.94% | 57.28% | Upgrade |
Cash Acquisitions | -76 | -76 | -563 | -2,155 | -380 | -1,403 | Upgrade |
Investment in Securities | -120 | -121 | -223 | -63 | -8,668 | -5,718 | Upgrade |
Other Investing Activities | - | -211 | - | - | - | - | Upgrade |
Investing Cash Flow | -196 | -408 | -786 | -2,218 | -11,212 | -8,202 | Upgrade |
Long-Term Debt Issued | - | - | 61 | 1,792 | 63 | 4,252 | Upgrade |
Total Debt Repaid | -60 | -60 | -1,469 | -495 | -831 | -501 | Upgrade |
Net Debt Issued (Repaid) | -60 | -60 | -1,408 | 1,297 | -768 | 3,751 | Upgrade |
Issuance of Common Stock | 91 | 88 | 158 | 43 | 1,597 | 18 | Upgrade |
Repurchases of Common Stock | -217 | -114 | -233 | - | - | - | Upgrade |
Issuance of Preferred Stock | - | - | - | - | 200 | - | Upgrade |
Repurchases of Preferred Stock | - | - | - | - | -194 | - | Upgrade |
Common Dividends Paid | -2,119 | -2,069 | -1,937 | -1,826 | -1,677 | -1,626 | Upgrade |
Preferred Dividends Paid | -130 | -130 | -130 | -130 | -134 | -133 | Upgrade |
Total Dividends Paid | -2,249 | -2,199 | -2,067 | -1,956 | -1,811 | -1,759 | Upgrade |
Other Financing Activities | - | - | - | -4 | -16 | - | Upgrade |
Financing Cash Flow | -2,435 | -2,285 | -3,550 | -620 | -992 | 2,010 | Upgrade |
Foreign Exchange Rate Adjustments | 535 | 534 | -40 | 281 | -40 | -100 | Upgrade |
Net Cash Flow | 2,235 | 2,592 | 452 | 1,215 | -1,871 | 3,318 | Upgrade |
Cash Interest Paid | 410 | 410 | 453 | 408 | 348 | 286 | Upgrade |
Cash Income Tax Paid | 710 | 707 | 423 | 348 | 351 | 367 | Upgrade |
Levered Free Cash Flow | -10,322 | -5,238 | -9,019 | -32,728 | 1,945 | -19,161 | Upgrade |
Unlevered Free Cash Flow | -7,703 | -2,622 | -6,624 | -30,650 | 2,140 | -18,995 | Upgrade |
Change in Net Working Capital | 14,177 | 9,231 | 11,888 | 36,079 | 1,251 | 21,767 | Upgrade |
Source: S&P Global Market Intelligence. Insurance template. Financial Sources.